EXHIBIT 31.1
                 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
                  PURSUANT TO RULES 13a-14 AND 15d-14 OF THE
                        SECURITIES EXCHANGE ACT OF 1934

I, Wolfgang  Barnikol,  Chief Executive  Officer and Chief Financial  Officer of
Sangui BioTech International, Inc. (the *ompany"), certify that:

      I have reviewed  this  quarterly  report on Form 10-QSB of Sangui  BioTech
International, Inc.

      Based on my knowledge,  this quarterly  report does not contain any untrue
statement of a material fact or omit to state a material fact  necessary to make
the statements made, in light of the  circumstances  under which such statements
were made, not  misleading  with respect to the period covered by this quarterly
report.

      Based on my  knowledge,  the  financial  statements,  and other  financial
information included in the report,  fairly present in all material respects the
financial condition,  results of operations and cash flows of the Company as of,
and for, the periods, presented in the report.

      The  Company's  other  certifying   officer  and  I  are  responsible  for
establishing and maintaining  disclosure  controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the Company and have:

        (a) designed such  disclosure  controls and  procedures,  or caused such
        disclosure  controls and procedures to be designed under my supervision,
        to ensure that material information  relating to the Company,  including
        its  consolidated  subsidiaries,  is made  known to me by others  within
        those  entities,  particularly  during the period in which the  periodic
        report is being prepared;

        (b) evaluated the effectiveness of the Company's disclosure controls and
        procedures  and  presented  in this  report  our  conclusions  about the
        effectiveness of the disclosure  controls and procedures,  as of the end
        of the period covered by this quarterly report based on such evaluation;
        and

        (c)  disclosed  in this  quarterly  report any  change in the  Company's
        internal  control over  financial  reporting  that  occurred  during the
        Company's most recent fiscal quarter that has materially affected, or is
        reasonably likely to materially  affect,  the Company's internal control
        over financial reporting; and

      The Company's other certifying officer and I have disclosed,  based on our
most recent  evaluation of internal  control over  financial  reporting,  to the
Company's  auditors and to the audit  committee  of the board of  directors  (or
persons fulfilling the equivalent function):

        (i) all significant  deficiencies in the design or operation of internal
        control  over  financial   reporting  which  are  reasonably  likely  to
        adversely affect the Company's ability to record, process, summarize and
        report financial information; and

        (ii) any fraud,  whether or not material,  that  involves  management or
        other  employees who have a significant  role in the Company's  internal
        control over financial reporting.


Date: November 13, 2003                           By: /s/ Wolfgang Barnikol
                                                  ----------------------------
                                                  Wolfgang Barnikol, Chief
                                                  Executive Officer and Chief
                                                  Financial Officer